URL has been copied successfully!
URL has been copied successfully!
Skip to content
JBizNews
Primary Navigation Menu
Menu
Home
Breaking News
Top News
Markets
Crypto
Health
Real Estate
Events
Subscribe
About JBizNews
Search for:
Search Button
Jefferies Sees Reduced Upside for Arbutus Biopharma Corporation (ABUS) on Higher Appeal Probability
By:
Yahoo News
On:
April 17, 2026
URL has been copied successfully!
Please follow us:
2026-04-17
Previous Post:
Morgan Stanley Updates Bicycle Therapeutics plc (BCYC) Outlook Amid Pipeline Refocus
Next Post:
Mizuho Sees Strong Risk-Reward in Corbus Pharmaceuticals Holdings, Inc. (CRBP) Near Cash Value